A case of an infant suspected as IMAGE syndrome who were finally diagnosed with MIRAGE syndrome by targeted Mendelian exome sequencing
- PMID: 29506479
- PMCID: PMC5836387
- DOI: 10.1186/s12881-018-0546-4
A case of an infant suspected as IMAGE syndrome who were finally diagnosed with MIRAGE syndrome by targeted Mendelian exome sequencing
Abstract
Background: Adrenal hypoplasia is a rare congenital disorder, which can be classified into a non-syndromic form, without extra-adrenal features, and a syndromic form, with such features. Despite biochemical and molecular genetic evaluation, etiologic diagnosis cannot be performed in many patients with adrenal hypoplasia.
Case presentation: The patient in this case was a boy born at 31 weeks of gestation with a weight of 882 g (< 3rd percentile) to non-consanguineous parents. Genital examination showed micropenis and bilateral cryptorchidism. On the third day of life, he manifested hypotension with high urine output, hyponatremia, hyperkalemia, hypernatriuria, high plasma adrenocorticotropic hormone level, and high plasma renin activity, suggesting acute adrenal insufficiency. The serum 17α-hydroxyprogesterone level was normal. Adrenal insufficiency improved following administration of hydrocortisone and 9α-fludrocortisone, but the patient died of recurrent infection at 4 months of age. He was suspected as IMAGE (Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies) syndrome. However, no mutation in CDKN1C was identified. Targeted exome sequencing using the TruSight One Sequencing Panel (Illumina) identified a heterozygous mutation of c.2944C > T (p.R982C) in exon 3 in SAMD9.
Conclusion: This report describes the first Korean case of MIRAGE syndrome. The patient presented with severe primary adrenal insufficiency, intrauterine growth retardation, and recurrent infection. SAMD9 mutation should be considered in patients who present with adrenal hypoplasia and extra-adrenal phenotypes.
Keywords: Congenital adrenal hypoplasia; MIRAGE syndrome; SAMD9.
Conflict of interest statement
Ethics approval and consent to participate
This study was approved by the Institutional Review Board and Ethics Committee of Asan Medical Center. Written, informed consent to participate was obtained for all participants, or their guardians, before blood samples were drawn.
Consent for publication
Written consent was obtained from the parents of patient for the publication, including child’s data.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
IMAGe syndrome: clinical and genetic implications based on investigations in three Japanese patients.Clin Endocrinol (Oxf). 2014 May;80(5):706-13. doi: 10.1111/cen.12379. Epub 2013 Dec 28. Clin Endocrinol (Oxf). 2014. PMID: 24313804
-
Case report: a premature infant with severe intrauterine growth restriction, adrenal insufficiency, and inflammatory diarrhea: a genetically confirmed case of MIRAGE syndrome.Front Endocrinol (Lausanne). 2023 Sep 6;14:1242387. doi: 10.3389/fendo.2023.1242387. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37745698 Free PMC article.
-
Novel mutation points to a hot spot in CDKN1C causing Silver-Russell syndrome.Clin Epigenetics. 2020 Oct 19;12(1):152. doi: 10.1186/s13148-020-00945-y. Clin Epigenetics. 2020. PMID: 33076988 Free PMC article.
-
Analysis of CDKN1C in fetal growth restriction and pregnancy loss.F1000Res. 2019 Jan 23;8:90. doi: 10.12688/f1000research.15016.2. eCollection 2019. F1000Res. 2019. PMID: 31497289 Free PMC article. Review.
-
IMAGe and Related Undergrowth Syndromes: The Complex Spectrum of Gain-of-Function CDKN1C Mutations.Pediatr Endocrinol Rev. 2017 Mar;14(3):289-297. doi: 10.17458/per.vol14.2017.SKHD.imageandrelatedundergrowth. Pediatr Endocrinol Rev. 2017. PMID: 28508599 Review.
Cited by
-
MIRAGE syndrome caused by a novel missense variant (p.Ala1479Ser) in the SAMD9 gene.Hum Genome Var. 2020 Mar 5;7:4. doi: 10.1038/s41439-020-0091-5. eCollection 2020. Hum Genome Var. 2020. PMID: 32194975 Free PMC article.
-
Acquired uniparental disomy of chromosome 7 in a patient with MIRAGE syndrome that veiled a pathogenic SAMD9 variant.Clin Pediatr Endocrinol. 2021;30(4):163-169. doi: 10.1297/cpe.30.163. Epub 2021 Oct 1. Clin Pediatr Endocrinol. 2021. PMID: 34629738 Free PMC article.
-
A Rare Etiology of 46,XY Disorder of Sex Development and Adrenal Insufficiency: A Case of MIRAGE Syndrome Caused by Mutations in the SAMD9 Gene.J Clin Res Pediatr Endocrinol. 2020 Jun 3;12(2):206-211. doi: 10.4274/jcrpe.galenos.2019.2019.0053. Epub 2019 Jun 18. J Clin Res Pediatr Endocrinol. 2020. PMID: 31208161 Free PMC article.
-
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes.Nat Med. 2021 Oct;27(10):1806-1817. doi: 10.1038/s41591-021-01511-6. Epub 2021 Oct 7. Nat Med. 2021. PMID: 34621053 Free PMC article.
-
Diverse etiologies, diagnostic approach, and management of primary adrenal insufficiency in pediatric age.Ann Pediatr Endocrinol Metab. 2021 Sep;26(3):149-157. doi: 10.6065/apem.2142150.075. Epub 2021 Sep 30. Ann Pediatr Endocrinol Metab. 2021. PMID: 34610702 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources